Market Access today is more than just securing formulary status, it’s about navigating a complex, evolving ecosystem of payers, patients, providers, and policies. Chryselys’ Market Access Intelligence delivers a comprehensive, AI-powered approach to decoding access challenges, optimizing contracts, and enabling confident prescribing decisions.
Built for real-world market complexity, our solution blends structured datasets (claims, rebates, access metrics) with unstructured sources (payer policy PDFs, formulary docs, coverage restrictions) to provide a 360° view of the access landscape.
Pinpoint restrictions like PA, ST, NDC rejections, and plan-level exclusions
Align IQVIA, MMIT, HUB data through a robust payer MDM layer
Forecast leakage, model scenarios, and refine contract performance
Map competitor access shifts and coverage trends
Support field teams and HCPs with accurate, real-time coverage clarity
Identify root causes and reduce abandonment
Formulary access, contract strategy, G2N analytics, IRA forecasting
Launch readiness, competitive intelligence, field planning
Denial analytics, copay program optimization, patient journey mapping
Payer policy extraction, evidence generation, coverage impact modeling
Unified payer data management and analytics-ready datasets
Our unified solution synthesizes multiple datasets and stakeholder needs into a single, analytics-ready intelligence layer.
Combines claims, coverage documents, formulary data, and PDFs into one cohesive intelligence layer.
Crosswalks IQVIA ↔ MMIT ↔ SP/HUB, resolving inconsistencies with GenAI + human stewardship.
Our AI models are backed by rigorous manual validation for accuracy and refinement.
Extracts policy nuances, flags anomalies, and generates research summaries—at scale.
Supports Oncology, Immunology, CNS, Rare, CV/Metabolic, and more.
